Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 9 10 11 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Micro-Macinazione–Lonza: investment, 201707 acquisition €na of Micro-Macinazione from Cross Equity Fund 2017-07-26
DiaSorin–Siemens: ELISA immunoassays, 201707– acquisition up to €47.5m of Siemens ELISA Dx portfolio/assets without employees + mftg capacity 2017-07-25
Protembis–Germany (govt): business development, 201707– supply service support in US with German Accelerator Life Sciences programme 2017-07-25
Bayer–Evotec: drug discovery services, 201707–201812 collab extension endometriosis alliance after reaching milestone of start of phase 1 2017-07-24
Boehringer–Philogen: drug discovery services, 201707– collab €na discovery + optimisation of small molecule drugs using ESAC technology 2017-07-20
SpinDiag–SEVERAL: investment, 201707 seed financing round €1.6m from three private investors 2017-07-20
Humabs BioMed–MC Services: public relations, 201707 service existent by MC Services AG 2017-07-18
Maruho–4SC: Kv1.3 inhibitors, 201707– license ww excl for up to total €208m upfront + milestones plus single-digit royalties 2017-07-18
Shire–Novimmune: therapeutic antibodies, 201707– license ww excl €na to bispecific antibody for hemophilia A 2017-07-18
TomTec Imaging–Philips: investment, 201707– acquisition €na of TomTec Imaging Systems GmbH by Philips ANNOUNCED 2017-07-18
BASF–Kaiima: plant biotechnology, 201707– collab research multi-year using EP technology to discover herbicide resistent traits 2017-07-17
Diagenode–PreOmics: proteomic sample preparation, –201707 collab developm combi of Bioruptor + iST Kit to clean peptides for MS 2017-07-14
NofaGroup–Cotecna: investment, 201707 acquisition of NofaGroup by Cotecna Inspection SA 2017-07-13
ABF–Genedata: bioinformatics, 201707– supply expansion use of Genedata Selector by AB Enzymes for decision support 2017-07-11
Blueprint Genetics–Creathor Venture: investment, 201707 financing round totalling up to €14m incl new + co-lead investor Creathor Venture 2017-07-11
Blueprint Genetics–Inventure: investment, 201707 financing round totalling up to €14m incl existing + co-investor Inventure 2017-07-11
Blueprint Genetics–MedTech Innovation Partners: investment, 201707 financing round totalling up to €14m incl new + co-lead investor MTIP 2017-07-11
Blueprint Genetics–Pontos Group: investment, 201707 financing round totalling up to €14m incl existing + co-investor Pontos Group 2017-07-11
Blueprint Genetics–SEVERAL: investment, 201707 financing round up to €14m led by Creathor Venture + MTIP + incl Inventure + Pontos Group 2017-07-11
Nestlé–Enterome: diagnostics, 201707– collab establishm of 50/50 jv MDP to develop microbiome-based diagnostics except for immuno-oncology 2017-07-11
CRISPR Therapeutics–Neon Therapeutics: T cell therapy, 201707– collab combi of proprietary technologies to develop T cell therapies 2017-07-10
Endress+Hauser–GUS Group: investment, 201707 acquisition of AJ Blomesystem GmbH by GUS Group 2017-07-01
Evotec–Hamburg (govt): grant, 201707– 201906 RnD grant from IFB Hamburg to develop AB-based cancer therapies with UKE 2017-07-01
Global Bioenergies–SEVERAL: investment, 201706 capital increase €10.24m via private placement of 640k new shares at €16/share 2017-06-30
mySugr–Roche: investment, 201706 acquisition of remaining shares by Roche 2017-06-30
Evotec–Censo Biotechnologies: stem cell technology, 201706–201905 strategic collab €na with Censo supplying iPS cell lines to Evotec 2017-06-28
Indi Molecular–Merck (DE): investment, 201706 financing round Series A totalling $11.5m led by Merck Ventures + Legend Capital 2017-06-28
Indi Molecular–SEVERAL: investment, 201706 financing round Series A $11.5m led by Merck Ventures + Legend Capital 2017-06-28
BioGeneration Ventures–EU (govt): investment, 201706 investment by EIF + other new investors bringing total capital of BGV III to €66m 2017-06-27
BioGeneration Ventures–SEVERAL: investment, 201706 investm by EIF + other new investors bringing total capital of BGV III to €66m with max target €75m 2017-06-27
CatalYm–BioGeneration Ventures: investment, 201706 CatalYm GmbH is existent investment of BGV III fund 2017-06-27
Sensovation–Miltenyi Biotec: investment, 201706 acquisition by Milteny from HeidelbergCapital + KfW/tbg 2017-06-27
Takeda–JSR Corp: cell line development, 201706– commercial license to use Selexis’ SUREtechnology for developm of fusion proteins 2017-06-27
Ottobock–EQT: investment, 201706 EQT VII fund to acquire 20% stake from Otto Bock HealthCare GmbH valuing Ottobock at €3.15b 2017-06-24
DiaSorin–Qiagen: in vitro diagnostics, 201706– collab to adopt select Qiagen assays for use on Liaison platform 2017-06-22
AlsaChim–Shimadzu: investment, 201706 acquisition €na of 100% of AlsaChim by Shimadzu Europe 2017-06-21
FB Health–Invent Farma/Neuraxpharm: investment, 201706 acquisition €na of FB Health by Invent Farma/Neuraxpharm (formed 8/16 by Apax Partners) 2017-06-21
Debiopharm–Almac: kinase inhibitor, 201706– license ww excl to Wee-1 kinase inhibitor programme of Almac Discovery 2017-06-20
Facio Therapies–Evotec: investment, 201706c financing round totalling €4.8m incl strategic investment by Evotec 2017-06-20
Facio Therapies–SEVERAL: investment, 201706c financing round €4.8m incl Evotec + members of intl FSHD community 2017-06-20
Idorsia–JnJ: investment, 201706 acquisition of 9.9% share in Idorsia by Cilag Holding AG via conversion of CFH135.4m convertable loan 2017-06-20
Euroimmun–PerkinElmer: investment, 201706–201712 acquisition $1.3b in cash 2017-06-19
Takeda–Wilex: antibody-drug conjugates, 201706– collab developm of ADCs using ATACs for up to 3 targets Heidelberg Pharma + Millennium 2017-06-19
TxCell–Miltenyi Biotec: lentiviral vector, 201706– supply of lentiviral vector for TxCell’s CAR-Tregs targeting transplant rejection by Lentigen 2017-06-19
Broughton Laboratories–Thermo Fisher: LC system, 201706 supply two Vanquish Flex UPLC systems coupled to TSQ Endura TQ-MS detectors 2017-06-16
Broughton Laboratories–Thermo Fisher: mass spectrometer, 201706 supply two Vanquish Flex UPLC systems coupled to TSQ Endura TQ-MS detectors 2017-06-16
GreenBone–Helsinn: investment, 201706 2nd financing round incl €2m from lead investor Helsinn Investment Fund 2017-06-16
GreenBone–SEVERAL: investment, 201706 2nd financing round incl lead investor Helsinn Investment Fund 2017-06-16
Idorsia–OTHER: investment, 201706 listing at SIX Swiss Exchange as part of acquisition of Actelion by JnJ and spin-off of Idorsia 2017-06-16
Medicxi Ventures–Alphabet: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–EU (govt): investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–Novartis: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
Medicxi Ventures–SEVERAL: investment, 201706 closing $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
TissUse–Minapharm: organ-on-a-chip technology, 201706– license for HuALN platform for Multi-Organ-Chip applications from ProBioGen 2017-06-15
Bayer–China (govt): wheat breeding, 201706– collab 2y with SIBS + SIPPE to improve wheat yields via improved photosynthetic efficiency 2017-06-14
Pfizer–Basilea: isavuconazole, 201706– license CHF70m upfront + $427m milestones + royalties for prod + sales in Europe + RU + TR + IL 2017-06-14
Selexis–JSR Corp: investment, 201706 acquisition €na of Selexis SA by JSR Life Sciences 2017-06-14
Centogene–Careventures: investment, 201706 financing round Series A totalling €25m incl co-investor Careventures 2017-06-13
Centogene–Crédit Mutuel-CIC: investment, 201706 financing round Series A totalling €25m incl co-investor CIC Capital 2017-06-13
Centogene–DPE Deutsche Private Equity: investment, 201706 financing round Series A totalling €25m incl co-investor DPE 2017-06-13
Centogene–SEVERAL: investment, 201706 financing round Series A €25m led by TVM Capital + incl DPE + Careventures + CIC Capital 2017-06-13
Centogene–TVM: investment, 201706 financing round Series A totalling €25m incl lead investor TVM Capital Life Science 2017-06-13
CureVac–TiberendStrategic Advisors: public relations, 201706 service existent by Tiberend 2017-06-13
4SC–SEVERAL: investment, 201706–201707 cash capital increase €41m with 11.68m new shares at €3.5/share 2017-06-12
TeneoBio–Selexis: cell line development, 201706– supply service access to SUREtechnology platform to develop cell expression of UniAbs 2017-06-12
Lilly–Nordic Bioscience: antidiabetic, 201706– strategic collab $55m upfront + milestones + royalties ww rights to develop DACRAs from KeyBioscience 2017-06-08
Grünenthal–AstraZeneca: zolmitriptan, 201706 acquisition ww rights excl JP to Zomig $200m upfront + $102m milestones by Grünenthal 2017-06-07
Omeicos–Germany (govt): grant, 201706– additional BMBF research grant €1.7m 2017-06-07
CRISPR Therapeutics–Orgenesis: CAR-T cell therapies, 201706– supply CDMO services for allogenic CAR-T therapy CTX101 by MaSTherCell SA 2017-06-06
Thermo Fisher–Biocrates: AbsoluteIDQ Kits, 201706– collab co-marketing of new AbsoluteIDQ p400 HR Kit with Q Exactive HRAM MS systems 2017-06-05
Thermo Fisher–Biognosys: mass spectrometry s/w, 201706– collab co-marketing of Spectronaut Pulsar s/w with Orbitrap mass spectrometers 2017-06-05
Univ Maastricht–Bruker Corp: mass spectrometry software, 201706 supply existent use of SCilS Lab s/w by M4I 2017-06-05
Merck (DE)–F-Star: antibody cancer drug, 201706– strategic collab €115m upfront + €1b milestones develop 5 bispecific ABs incl lead asset FS118 2017-06-04
BMS–Qiagen: molecular companion diagnostics, 201706– collab using NGS to develop gene expression profiles for cancer immunotherapies 2017-06-03
Qiagen–Johns Hopkins Univ: cancer biomarker, 201705– license ww to genetic biomarkers for use in I-O patient selection 2017-06-03
GATC Biotech–Eurofins: investment, 201706–201707 acquisition €na of GATC Biotech AG by Eurofins Scientific SE 2017-06-02
Bicycle Therapeutics–SEVERAL: investment, 201706 financing round Series B £40m led by new investor Vertex Ventures HC 2017-06-01
Indivumed–LADR/Intermed: investment, 201706 investment by Intermed as part of strategic alliance 2017-06-01
Waters–Andrew Alliance: automated liquid handling technology, 201706– collab co-marketing semi-automated sample prep solution 2017-06-01
Inthera Bioscience–SEVERAL: investment, 201705 financing round Series A CHF10.5m Merck Ventures + Aglaia BioMedical + Novo Seeds + private investor 2017-05-31
Strekin–SEVERAL: investment, 201705 financing round Series C CHF10m from private investors 2017-05-31
High-Tech Gründerfonds–SEVERAL: investment, 201705 first closing €245m of High-Tech Gründerfonds III (HTGF III) 2017-05-30
Taconic–ERS Genomics: CRISPR technology, 201705– license ww non-excl for CRISPR-Cas9 technology to generate murine models 2017-05-30
ViraTherapeutics–MC Services: public relations, 201705 service existent by MC Services 2017-05-30
Wise (IT)–SEVERAL: investment, 201705 financing round Series B €6.5m led by Prinicpia SGR + incl Atlante Ventures + HTGF + F3F + Antares 2017-05-25
Debiopharm–ImmunoGen: antibody-drug conjugate, 201704 acquisition $25m upfront + $30m milestones of anti-CD37 ADC IMGN529 by Debiopharm 2017-05-24
Sartorius–SEVERAL: credit, 201705– note loan €350m with maturity terms of 5, 7 + 10 years arranged by Commerzbank + LBBW 2017-05-24
OSE Immunotherapeutics–Selexis: cell line development, 201705– commercial license for access to RCBs from SUREtechnology platform 2017-05-23
Signatope–High-Tech Gründerfonds: investment, 201705 investment €600k by HTGF 2017-05-23
TolerogenixX–High-Tech Gründerfonds: investment, 201705 seed financing from HTGF 2017-05-23
Clariant–Huntsman: investment, 201705–201710 merger of equals NOT REALISED 2017-05-21
Boehringer–Anagenesis: drug discovery technology, 201705– excl license to P2MC technology for drug developm for chronic muscle diseases 2017-05-18
Boehringer–Peking Univ: pharma r+d, 201705– collab strategic alliance incl therapeutics + regenerative medicine + gene therapy 2017-05-16
Exosomics Siena–Lonza: investment, 201705 strategic investment by Lonza 2017-05-16
HansaBioMed Life Sciences–Lonza: investment, 201705 acquisition of HBM-LS by Lonza 2017-05-16
Vesalius Biocapital–SEVERAL: investment, 201705 first closing €65m of Vesalius Biocapital III fund 2017-05-15
Cardior Pharmaceuticals–SEVERAL: investment, 201705 financing round Series A €15m led by LSP + BIVF + BMS + BioMedPartners + HTGF 2017-05-11
Numaferm–EU (govt): investment, 201705 seed financing round totalling €7-digit incl European Investment Fund 2017-05-11
Numaferm–High-Tech Gründerfonds: investment, 201705 seed financing round totalling €7-digit incl HTGF 2017-05-11
Numaferm–PERSON: investment, 201705 seed financing round totalling €7-digit incl business angels + Qiagen founders Detlev Riesner + Jürgen Schumacher 2017-05-11
next pagenext page 1 2 3 ... 9 10 11 ... 55 56 57  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top